Prevalence of Erectile Dysfunction in Atrial Fibrillation Patients: A Cross-Sectional, Epidemiological Study

被引:14
|
作者
Platek, Anna E. [1 ]
Hrynkiewicz-Szymanska, Anna [2 ]
Kotkowski, Marcin [1 ]
Szymanski, Filip M. [1 ]
Syska-Suminska, Joanna [2 ]
Puchalski, Bartosz [1 ]
Filipiak, Krzysztof J. [1 ]
机构
[1] Med Univ Warsaw, Dept Cardiol 1, PL-02097 Warsaw, Poland
[2] Med Univ Warsaw, Dept Cardiol Hypertens & Internal Dis, Warsaw, Poland
来源
关键词
atrial fibrillation; quality of life; erectile dysfunction; OBSTRUCTIVE SLEEP-APNEA; MYOCARDIAL-INFARCTION; INTERNATIONAL INDEX; RISK-FACTOR; MEN; INFLAMMATION; DISEASE; COMMON;
D O I
10.1111/pace.12753
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Sexual dysfunctions, especially erectile dysfunction (ED), are a major problem in cardiovascular patients. They are caused by cardiovascular risk factors including low-grade inflammation process, endothelial dysfunction, oxidative stress, and hemodynamic and vascular alterations. The same mechanisms are some of the main causes and/or consequences of atrial fibrillation (AF). To this day, literature provides no cross-sectional data on the prevalence of sexual dysfunction in AF. The study aimed to determine the prevalence of sexual dysfunction in consecutive, young male patients with AF. Material and Methods: A cross-sectional survey of adult male patients with a primary diagnosis of AF was conducted at University Cardiology Departments, during the period of July 2013 to July 2014. During the enrollment process, the study participants were either electively hospitalized with a primary diagnosis of AF, or had a scheduled outpatient visit. Sexual dysfunctions were assessed using the International Index of Erectile Function. Results: A total of 129 consecutive AF patients (mean age 57.0 11.8 years) were analyzed. Hypertension was present in 60.5%, diabetes in 22.5% of patients, 46.5% had dyslipidemia, 18.6% were current smokers, and 45.7% had a family history of cardiovascular disease. At least one kind of sexual dysfunction was found in 86.8% of patients. ED was present in 57.4% of patients, 44.2% of patients had orgasmic dysfunction, 69.0% had lowered sexual desire, 65.1% had lowered intercourse satisfaction, and 55.8% had lowered overall satisfaction. Conclusions: Sexual dysfunctions are highly prevalent in AF patients and are not only limited to ED, but also include dysfunction of orgasmic function, desire, or general satisfaction. In part, the presence of the sexual dysfunctions is probably caused by classical cardiovascular risk factors highly prevalent in AF patients, but the impact of AF itself cannot be underestimated.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [1] Prevalence of erectile dysfunction in atrial fibrillation patients - cross-sectional, epidemiological study
    Platek, A. E.
    Szymanski, F. M.
    Filipiak, K. J.
    Kotkowski, M.
    Opolski, G.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 900 - 900
  • [2] PREVALENCE OF ERECTILE DYSFUNCTION IN HYPERTHYROID PATIENTS: A CROSS-SECTIONAL STUDY
    Rezaeidanesh, M.
    Shahnazari, A.
    Rasouli, M. R.
    Nikoobakht, M. R.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 588 - 588
  • [3] Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study
    Shi, Shaobo
    Tang, Yanhong
    Zhao, Qingyan
    Yan, Hong
    Yu, Bin
    Zheng, Qiangsun
    Li, Yigang
    Zheng, Liangrong
    Yuan, Yiqiang
    Zhong, Jingquan
    Xu, Jian
    Wu, Yanqing
    Xu, Jing
    Chen, Lin
    Li, Shufeng
    Jiang, Jian
    Wang, Jingfeng
    Fan, Jie
    Chen, Minglong
    Tang, Baopeng
    Li, Wei
    Wu, Qiang
    Shi, Bei
    Zhou, Shenghua
    Zhao, Xingsheng
    Yin, Yuehui
    Zhang, Zheng
    Zhong, Guoqiang
    Han, Xuebin
    Liu, Fan
    Wu, Ming
    Gao, Lianjun
    Yang, Bo
    Huang, He
    Huang, Congxin
    behalf China Atrial Fibrillation Ctr Project Team
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 23
  • [4] ATRIAL FIBRILLATION: PREVALENCE AND CROSS-SECTIONAL DETERMINANTS IN A CKD PATIENTS
    Dimitrijevic, Zorica
    Mitic, Branka
    Paunovic, Goran
    Cvetkovic, Mina
    Vrecic, Tamara
    Randjelovic, Jelena
    Jovanovic, Andrijana
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [5] Prevalence, risks, and comorbidity of thyroid dysfunction: a cross-sectional epidemiological study
    Nearmeen M. Rashad
    Ghada M. Samir
    [J]. The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 635 - 641
  • [6] Prevalence of erectile dysfunction and active depression: An analytic cross-sectional study of general medical patients
    Kantor, J
    Bilker, WB
    Glasser, DB
    Margolis, DJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (11) : 1035 - 1042
  • [7] Cross-sectional, controlled epidemiological study investigating erectile dysfunction and late onset hypogonadism in leprosy patients
    Guler, H.
    Silay, M. S.
    Kadihasanoglu, M.
    Tanriverdi, O.
    Aydin, M.
    Miroglu, C.
    Kendirci, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 673 - 673
  • [8] Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study
    Maida, Carlo Domenico
    Vasto, Sonya
    Di Raimondo, Domenico
    Casuccio, Alessandra
    Vassallo, Valerio
    Daidone, Mario
    Del Cuore, Alessandro
    Pacinella, Gaetano
    Cirrincione, Anna
    Simonetta, Irene
    Della Corte, Vittoriano
    Rizzica, Salvatore
    Geraci, Giulio
    Tuttolomondo, Antonino
    Pinto, Antonio
    [J]. AGING-US, 2020, 12 (09): : 8423 - 8433
  • [9] A cross-sectional study of atrial fibrillation in community hypertensive patients
    张莹
    冯颖青
    韦瑞斌
    吴樱
    莫与京
    黄雨晴
    [J]. South China Journal of Cardiology, 2014, 15 (01) : 27 - 32
  • [10] Erectile Dysfunction in Patients with Multiple Chronic Conditions: A Cross-Sectional Study
    Lisco, Giuseppe
    Bartolomeo, Nicola
    Ramunni, Maria Isabella
    De Tullio, Anna
    Carbone, Matteo Domenico
    Guastamcchia, Edoardo
    De Pergola, Giovanni
    Triggiani, Vincenzo
    Giagulli, Vito Angelo
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (03) : 396 - 404